Cabrinie Barnes of Stamford was caught with more than a quarter-pound of fentanyl and a trove of other drugs during a raid ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with ...

In December, Tonix announced that the U.S. Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025, for a decision on marketing authorization ...

for a decision on marketing authorization for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia. * Tonix’s product development candidates are ...

for a decision on marketing authorization for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia. TNX-102 SL is a non-opioid, centrally-acting analgesic.

In December, Tonix announced that the U.S. Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025, for a decision on marketing authorization ...

14 (10/07/1998) 59, F Droperidol 0.625 mg i.v., cyclobenzaprine 10 mg po, fluoxetine, HCTZ/triamterene, amlodipine, diclofenac, simvastatin, anesthesia, atracurium ...

F Droperidol 0.625 mg Cardiac failure Hospitalization 14 (10/07/1998) 59, F Droperidol 0.625 mg i.v., cyclobenzaprine 10 mg po, fluoxetine, HCTZ/triamterene, amlodipine, diclofenac, simvastatin ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...

for a decision on marketing authorization for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia. TNX-102 SL is a non-opioid, centrally-acting analgesic.